Here are Tuesday's biggest analyst calls: Nvidia, Apple, AMD, Etsy, Eli Lilly, Samsara & more

Tuesday's Wall Street calls were broadly constructive, led by upgrades or buy initiations across technology, healthcare, infrastructure, consumer and financial services. Notable upside targets included Vishay at 38%, New York Times at about 20%, while Guggenheim raised Agilon's target to $125 from $86 and UBS lifted Palantir's target to $250 from $220. AI-related commentary was particularly bullish, with positive views on Nokia's optical-networking exposure, Etsy's AI-search catalyst, Apple iPhone demand, Amazon AWS, and Palantir's robust AI-platform demand.

Analysis

The actionable signal is not the individual rating changes but the concentration of bullish research around AI-adjacent physical infrastructure: networking, optical transport, grid-design software and IoT telemetry. This broadens the AI capex trade beyond NVDA/AMD, where valuation sensitivity to incremental estimate revisions is highest. NOK and BSY offer potentially lower-beta participation if hyperscaler spending shifts from compute procurement toward network bandwidth, power delivery and project execution over the next 6-18 months; the key verification point is whether backlog conversion and gross-margin mix improve, not management TAM language.

PLTR and IOT remain the higher-quality software expressions, but both are vulnerable to multiple compression if bookings growth merely remains strong rather than accelerates. The market is increasingly rewarding evidence of deployment-scale monetization, which makes quarterly net retention, large-customer additions and remaining-performance-obligation growth more important than AI-event commentary. A deceleration in commercial bookings, even with intact revenue guidance, would likely trigger a sharper drawdown in these premium-multiple names than in infrastructure beneficiaries.

Consumer and healthcare upgrades present a more idiosyncratic setup. ULTA's risk/reward has improved only if promotional intensity is peaking; sustained gross-margin stability through the holiday assortment cycle would force estimates higher, while a renewed discounting cycle would invalidate the rebound case quickly. LLY and RMD have clearer structural demand support, but LLY requires continued supply expansion to convert demand into revenue, while RMD's earnings durability depends on keeping share gains and operating leverage intact as competitive supply normalizes.

Consensus may be underestimating the second-order beneficiary of datacenter investment: electrical-grid and industrial-design software rather than another compute vendor. Conversely, the sheer volume of positive coverage is a short-term sentiment risk; absent earnings revisions, upgrades alone should not be chased over the next several sessions.

Key Decisions for Investors

• Build a 3-6 month pair trade: long BSY / short PLTR in equal dollar amounts. BSY provides less-crowded exposure to grid and resource-project capex, while PLTR carries greater multiple risk if next-quarter bookings do not accelerate. Reassess if BSY organic recurring-revenue growth misses guidance or PLTR raises forward revenue and margin expectations materially.
• Accumulate NOK on pullbacks rather than following rating-driven strength; size as a 6-12 month AI-networking satellite position. The thesis requires order intake and optical/network-infrastructure margins to improve over the next two reporting periods; exit on a material backlog decline or margin-guide cut.
• Maintain core long NVDA and AMZN, but fund incremental AI exposure through infrastructure enablers rather than adding to compute beta. A break in hyperscaler capex guidance or evidence that AI workloads are being served with lower networking intensity would invalidate this basket-level thesis.
• Use ULTA as a tactical 1-3 month long only if channel data confirm stable traffic and reduced promotional activity; target a rerating toward prior peer-relative multiples, with risk defined by a gross-margin guide reduction or same-store-sales deceleration. Do not treat the rating change itself as the catalyst.
• Keep LLY long exposure hedged with defined-risk downside protection into supply and reimbursement updates. The upside case depends on volume conversion from additional capacity, while adverse formulary access, lower realized pricing, or a supply ramp delay would compress the premium multiple rapidly.